[{"Assets_0_Q2_USD":783870000.0,"CommonStockSharesOutstanding_0_Q2_shares":58749186.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-191422000.0,"NetIncomeLoss_1_Q2_USD":-109871000.0,"NetIncomeLoss_2_Q2_USD":-202949000.0,"StockholdersEquity_0_Q2_USD":532677000.0,"Ticker":"AGIO","CIK":"1439222","name":"AGIOS PHARMACEUTICALS, INC.","OfficialName":"Agios Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1422760526.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]